Skip to main content
. 2021 Sep 14;13(9):3192. doi: 10.3390/nu13093192

Table 2.

Baseline characteristics of the studied patients. Values are presented as means (SD) for normally distributed data.

Total (n = 39) Probiotics (n = 17) Placebo (n = 22) p-Value
Age 53.44 (14.13) 54.70 (10.19) 52.47 (16.73) 0.63
Gender
Male 28 11 17
Female 11 6 5
Diabetes mellitus
Yes 19 9 10
No 20 8 12
Hypertension
Yes 21 11 10
No 18 6 12
Metabolic characteristics
Height, m 1.64 (0.08) 1.62 (0.09) 1.65 (0.07) 0.21
Weight, kg 76.70 (13.45) 75.00 (14.80) 78.03 (12.51) 0.49
BMI, kg/m2 29.62 (8.46) 31.33 (12.02) 28.30 (3.90) 0.63
Nutritional intake
Average kcal 1731.82 (348.62) 1759.94 (408.39) 1710.09 (302.85) 0.66
Carbohydrate, g 202.79(40.86) 194.39 (46.82) 209.29 (35.35) 0.26
% of total kcal 46% 44% 48%
Total fat, g 67.23 (20.78) 67.46 (21.81) 61.31 (19.84) 0.34
% of total kcal 33% 34% 32%
Protein, g 85.16 (23.93) 91.64 (26.34) 80.16 (21.16) 0.14
% of total kcal 19% 20% 18%
Serum biochemistry
ALT, IU/L 72.02 (34.77) 70.29 (28.21) 73.36 (39.71) 0.78
AST, IU/L 46.92 (18.27) 44.35 (12.67) 48.90 (21.74) 0.44
GGT, IU/L 70.10 (54.41) 65.94 (34.07) 73.31 (66.69) 0.68
Triglycerides, mmol/L 2.06 (0.79) 2.04 (0.79) 2.09 (0.81) 0.84
Total Cholesterol, mmol/L 5.79 (0.89) 5.93(0.90) 5.68 (0.88) 0.38
Fasting glucose, mmol/L 5.34 (1.31) 5.13 (0.96) 5.50 (1.53) 0.38
Serum LiverFAST
Steatosis score 0.64 (0.15) 0.67 (0.16) 0.62 (0.14) 0.41
Fibrosis score 0.30 (0.20) 0.28 (0.17) 0.33 (0.22) 0.46
Activity score 0.42 (0.23) 0.42 (0.21) 0.43 (0.24) 0.85
Transient elastography
Liver stiffness, kPa 7.44 (2.76) 7.25 (2.76) 7.58 (2.82) 0.37
Controlled attenuated parameter, dB/m 333.51 (34.35) 339.11 (34.39) 329.18 (35.15) 0.71

ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; GGT, gamma-glutamyl transferase.